Lab+Life Scientist Oct 2014

Page 35

ausbiotech 2014

Some of the highlights in the AusBiotech 2014 program

AusBiotech 2014 will be utilising a networking Opening address

Hon. Ian Walker MP

Minister for Science, Information Technology, Innovation and the Arts

Accessing innovation around the world

Dr Sue Dillon

Global Therapeutic Area Head for Immunology for Janssen

The challenges for pharma and biotech in emerging markets - Focus on China and India

Prof Ian Edvalson

Partner, Wilson Sonsini Goodrich Rosati

The connection between medical research and business

Prof Frank Gannon

Director and CEO, QIMR Berghofer Medical Research Institute

The use and future development of biomarkers

Professor Yongzhang Luo

Founder and Chief Scientist, Protgen Ltd

Bench marking biotech: Initiatives for the development of the biotechnology sector in Asia Pacific and their impact

Rhenu Bhuller

Senior Vice President, Healthcare, Frost & Sullivan

Investors unplugged

Chair: Lawrence Gozlan

Chief Executive Officer, Scientia Capital

in the lead-up to and during AusBiotech 2014.

Global regulatory issues

Chair: Bernard O'Shea

Partner Norton Rose Fulbright

The platform can be utilised via your desktop or

New economy, new manufacturing

Chair: Julie Phillips

mobile device, making it easy to continue to interact

Chief Executive Officer, BioDiem

in real time as you keep updated with the latest

What does success look like?

Chair: Rob McInnes

Partner DibbsBarker

information at the conference.

What are we doing for commercialisation in Australia?

Chair: Helen Fisher

Leader - Life Sciences, Deloitte Australia

Translation from innovation to the clinic and beyond

Chair: Dr Mark Ashton

Senior Director, Commercial Engagement, Health, UniQuest

Focus on China

Chair: Glenn Cross

Chief Operating Officer, AusBiotech

Converging the relationship between industry, investors and academia

Chair: Dr Anna Lavelle

Chief Executive Officer, AusBiotech

The changing face of big pharma

Chair: Glenn Cross

Chief Operating Officer, AusBiotech

Introduction of biosimilars into Australia

Chair: Dr Chris Holloway

Founder and Group Director of Regulatory Affairs, ERA Consulting Group

and partnering platform for all participants of the AusBiotech national conference. The powerful application is an integrated mobile event application and business partnering system all in one that will provide delegates with a one-stop shop for all conference information and networking aspects at the conference. The 2014 AusBiotech platform features: • Ability to request and schedule 30-minute meetings with other attendees through the AusPartnering system. • Access to the full program and associated networking events. • Ability to view the profiles for all attendees including, speakers, sponsors, exhibitors and attendees. • Manage a personalised calendar of sessions, meetings and networking events. • Receive important updates and announcements

All full conference attendees have been able to gain access into the AusPartnering system since the end of September 2014. Public forum - can we make brain diseases of ageing a thing of the past? ‘Perspectives on dementia and Alzheimer’s and biotechnology’s role in treatments and prevention’ is a free event for the public to join and hear from a number of experts who will present their vision on what the future of cognitive diseases like dementia and Alzheimer’s looks like. The forum will be held on Friday, 31 October from 9.45 am to noon. All attendees must have their AusBiotech 2014 conference registration, exhibitor pass or public forum pass to attend. Concurrent agriculture and food biotechnology symposium Where is Australia’s global niche? - noon • Room 8, Gold Coast Convention & Exhibition Centre • More information and registration: ausbiotechnc.

• Technological advances that will transform livestock, horticulture and cropping industries. • How to navigate regulatory and legal barriers. • Emerging and enabling biotechnologies. An outstanding line-up of international and


national speakers from research and development,

This two-day agriculture and food biotechnology

business, commercialisation, and legal and regulatory

symposium will highlight how Australian food and

backgrounds will explain how Australia’s food and

agricultural companies can capitalise on biotechnology

agri-bio industry can secure its future as a niche

innovations by exploring:

provider of technology, services and products and how

• Macroeconomics of influencing Australia’s agri-bio industry.


• Thursday 30 - Friday 31 October 2014 | 9 am

Australian food and agri-bio companies can position themselves as the preferred providers. |

LAB+LIFE SCIENTIST - October 2014 | 35